The burgeoning hemp industry stands poised for explosive growth if the federal government makes the crucial step of rescheduling cannabis. Currently, its classification as a Schedule I drug creates monumental barriers to innovation, limits banking and investment options, and perpetuates discriminatory policies. Rescheduling would unlock a "Green Ru